Growth Disorders
Pipeline by Development Stage
Competitive Landscape
4 companies ranked by most advanced pipeline stage
Trial Timeline
Clinical trial activity over time
Showing 15 of 25 trials with date data
Clinical Trials (25)
Total enrollment: 865 patients across 25 trials
Saizen® E-Device User Trial
Treatment of Children and Adolescents With Growth Failure Associated With Primary IGF-1 Deficiency
Prepubertal Children With Growth Failure Associated With Primary Insulin-Like Growth Factor-1 (IGF-1) Deficiency
Genotropin Treatment in Short Prepubertal Children With Intra-Uterine Growth Retardation
Treatment Of Children With Short Stature At An Age Of 3-7 Years Who Were Born Small For Gestational Age
Study to Assess Long-term Effectiveness of Zomacton® and Treatment Adherence in Patients With Growth Hormone Deficiency or Ullrich-Turner Syndrome
To Assess the Level of Adherence of Subjects Receiving SAIZEN® Via Easypod™ in Columbia
To Assess the Level of Adherence of Subjects Receiving SAIZEN® Via Easypod™ in Middle East
To Assess the Level of Adherence of Subjects Receiving SAIZEN® Via Easypod™ (ECOS Taiwan, Indonesia, Singapore)
To Assess the Level of Adherence of Subjects Receiving SAIZEN® Via Easypod™ in Greece
To Assess the Level of Adherence of Subjects Receiving SAIZEN® Via Easypod™ in Argentina
To Assess the Level of Adherence of Subjects Receiving SAIZEN® Via Easypod™ in Spain
To Assess the Level of Adherence of Subjects Receiving SAIZEN® Via Easypod™ in Hungary
To Assess the Level of Adherence of Subjects Receiving SAIZEN® Via Easypod™ in Mexico
To Assess the Level of Adherence of Subjects Receiving SAIZEN® Via Easypod™ in Italy
Level of Adherence of Subjects Receiving SAIZEN® Via Easypod™ Electromechanical Device for Growth Hormone Treatment
To Assess the Level of Adherence of Subjects Receiving SAIZEN® Via Easypod™ in Slovakia
Level of Adherence of Subjects Receiving SAIZEN® Via Easypod™ in Czech Republic
To Assess the Level of Adherence of Subjects Receiving SAIZEN® Via Easypod™ in Austria
A Canadian, Multi-centre, Observational Registry to Study Adherence and Long Term Outcomes of Therapy in Pediatric Subjects Using SAIZEN® Via Easypod™ Auto-injector for Growth Hormone Treatment
To Assess the Level of Adherence of Subjects Receiving SAIZEN® Via Easypod™ in Australia
To Assess the Level of Adherence of Subjects Receiving SAIZEN® Via Easypod™ in South Korea
To Assess the Level of Adherence of Subjects Receiving SAIZEN® Via Easypod™ in France
To Assess the Level of Adherence of Subjects Receiving SAIZEN® Via Easypod™ in the UK
Evaluation of Convenience and Compliance of the Easypod™ Electronic Self-injector